GENEWIZ Executive and Leadership Team

July, 2026

Leadership Overview

GENEWIZ has 4 executives leading key functions including strategy, finance, and operations.

Driven by innovation, GENEWIZ provides comprehensive R&D genomics services, empowering scientific discovery through advanced sequencing, synthesis, and bioinformatics solutions.

Leadership Roles at GENEWIZ

  • Chief Executive Officer - Anifa Kabale
  • Chief Financial Officer, Sample Management Solutions - Susheelan Variyathe
  • Divisional Chief Financial Officer, Genewiz - James Dorey
  • Executive Vice President & Chief Financial Officer - Lawrence Lin
  • Anifa Kabale - Chief Executive Officer

    Anifa Kabale, the Chief Executive Officer at GENEWIZ, directs the company's overarching strategy and operational execution. Overseeing all business units, Kabale ensures alignment with the mission to advance R&D genomics services. This leadership involves driving innovation in Sanger DNA sequencing, gene synthesis, and molecular biology. By fostering cross-functional collaboration, Anifa Kabale enhances the delivery of high throughput/next-generation sequencing and bioinformatics solutions. The focus remains on expanding market reach and solidifying GENEWIZ's position as a premier R&D partner. Kabale's strategic vision guides the company's commitment to providing GLP regulatory services, supporting critical research and development initiatives globally. The Chief Executive Officer's mandate includes cultivating a culture of scientific excellence and client-centric service delivery, ensuring GENEWIZ consistently meets the evolving needs of the research community.
    Anifa Kabale

    Susheelan Variyathe - Chief Financial Officer, Sample Management Solutions

    Susheelan Variyathe, the Chief Financial Officer, Sample Management Solutions at GENEWIZ, manages the financial health and strategic fiscal planning for the sample management division. Overseeing all financial operations within this segment, Variyathe ensures robust resource allocation and profitability. This role involves developing and implementing financial strategies that support the growth of sample management services. By meticulously analyzing financial data, Susheelan Variyathe identifies opportunities for cost optimization and revenue enhancement. The Chief Financial Officer, Sample Management Solutions also collaborates with other executive leaders to align financial objectives with the company's broader R&D genomics service goals. Variyathe's expertise is critical in maintaining financial integrity and driving sustainable business performance across the sample management solutions portfolio, ensuring efficient operations and investor confidence.

    James Dorey - Divisional Chief Financial Officer, Genewiz

    James Dorey, the Divisional Chief Financial Officer, Genewiz at GENEWIZ, directs the financial strategy and oversight for the core Genewiz operations. Managing the financial performance of the R&D genomics services, Dorey ensures fiscal discipline and strategic investment. This position requires a deep understanding of the market dynamics impacting gene synthesis, sequencing, and bioinformatics. By providing critical financial insights, James Dorey supports executive decision-making to drive operational efficiency and profitability. The Divisional Chief Financial Officer, Genewiz also oversees budgeting, forecasting, and financial reporting, ensuring compliance and transparency. Dorey's leadership is essential for optimizing financial resources to support the company's mission of advancing scientific discovery through its comprehensive service offerings, including GLP regulatory services.

    Lawrence Lin - Executive Vice President & Chief Financial Officer

    Lawrence Lin, the Executive Vice President & Chief Financial Officer at GENEWIZ, holds comprehensive responsibility for the company's financial strategy and management. Overseeing all financial functions, Lin drives fiscal planning, investment strategies, and resource allocation across the organization. This executive role involves ensuring the financial viability and growth of GENEWIZ's diverse R&D genomics services, including Sanger sequencing, gene synthesis, and next-generation sequencing. By providing strategic financial guidance, Lawrence Lin supports the expansion of molecular biology and bioinformatics capabilities. The Executive Vice President & Chief Financial Officer also manages relationships with financial institutions and stakeholders, ensuring robust capital structures and investor confidence. Lin's leadership ensures that financial operations effectively support the company's commitment to scientific innovation and client success in the global research market.

    Explore Leadership Teams in Business Services

    Frequently Asked Questions Regarding GENEWIZ Top Executives and Leadership Team

    Who leads GENEWIZ?
    GENEWIZ is led by Anifa Kabale (Chief Executive Officer), along with executives such as Susheelan Variyathe (Chief Financial Officer, Sample Management Solutions) and James Dorey (Divisional Chief Financial Officer, Genewiz).
    Who is part of GENEWIZ’s executive team?
    The executive team of GENEWIZ includes leaders such as Anifa Kabale (Chief Executive Officer), Susheelan Variyathe (Chief Financial Officer, Sample Management Solutions), James Dorey (Divisional Chief Financial Officer, Genewiz) and other senior executives.
    How many executives does GENEWIZ have?
    GENEWIZ has 4 executives leading key business areas.
    What roles are included in GENEWIZ’s leadership team?
    The leadership team of GENEWIZ includes roles such as Chief Executive Officer, Chief Financial Officer, Sample Management Solutions, Divisional Chief Financial Officer, Genewiz, Executive Vice President & Chief Financial Officer.